Faye Turner

698 total citations
15 papers, 529 citations indexed

About

Faye Turner is a scholar working on Oncology, Molecular Biology and Dermatology. According to data from OpenAlex, Faye Turner has authored 15 papers receiving a total of 529 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 6 papers in Molecular Biology and 2 papers in Dermatology. Recurrent topics in Faye Turner's work include Cutaneous Melanoma Detection and Management (6 papers), Colorectal Cancer Treatments and Studies (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Faye Turner is often cited by papers focused on Cutaneous Melanoma Detection and Management (6 papers), Colorectal Cancer Treatments and Studies (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Faye Turner collaborates with scholars based in United Kingdom, United States and Canada. Faye Turner's co-authors include D. Timothy Bishop, Jennifer H. Barrett, Julia Newton‐Bishop, Juliette A. Randerson‐Moor, Gillian Smith, David Forman, Linda Whitaker, C. Roland Wolf, Isabel dos‐Santos‐Silva and Anthony J. Swerdlow and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

Faye Turner

15 papers receiving 526 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Faye Turner United Kingdom 13 263 250 76 71 71 15 529
Sansanee Wongwaisayawan Thailand 13 204 0.8× 98 0.4× 115 1.5× 78 1.1× 80 1.1× 28 496
Ahmad Najem Belgium 15 264 1.0× 405 1.6× 113 1.5× 24 0.3× 83 1.2× 30 669
B W Futscher United States 7 324 1.2× 316 1.3× 53 0.7× 21 0.3× 21 0.3× 7 578
Yih-Jyh Lin Taiwan 14 110 0.4× 149 0.6× 104 1.4× 13 0.2× 64 0.9× 23 501
Chris S.R Hatton United Kingdom 14 234 0.9× 122 0.5× 22 0.3× 93 1.3× 37 0.5× 21 855
Yoo‐Kyung Lee South Korea 16 163 0.6× 178 0.7× 64 0.8× 12 0.2× 95 1.3× 32 707
Catherine Thériault Canada 9 133 0.5× 211 0.8× 38 0.5× 20 0.3× 28 0.4× 15 442
Sebastien K. Gerega Australia 8 128 0.5× 182 0.7× 75 1.0× 92 1.3× 31 0.4× 10 415
Ashwini Esnakula United States 13 174 0.7× 158 0.6× 114 1.5× 9 0.1× 79 1.1× 52 446
Sravanthi Cheeti United States 12 184 0.7× 293 1.2× 33 0.4× 69 1.0× 58 0.8× 28 522

Countries citing papers authored by Faye Turner

Since Specialization
Citations

This map shows the geographic impact of Faye Turner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Faye Turner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Faye Turner more than expected).

Fields of papers citing papers by Faye Turner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Faye Turner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Faye Turner. The network helps show where Faye Turner may publish in the future.

Co-authorship network of co-authors of Faye Turner

This figure shows the co-authorship network connecting the top 25 collaborators of Faye Turner. A scholar is included among the top collaborators of Faye Turner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Faye Turner. Faye Turner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Turner, Faye, Peter Watson, Michael M. Hawkins, et al.. (2012). P2 Apathy in long-term survivors of posterior fossa tumours in early childhood. Journal of Neurology Neurosurgery & Psychiatry. 83(10). e1.11–e1. 1 indexed citations
2.
3.
Freedberg, Daniel E., Julie E. Russak, Weiming Gai, et al.. (2008). Frequent p16-Independent Inactivation of p14ARF in Human Melanoma. JNCI Journal of the National Cancer Institute. 100(11). 784–795. 80 indexed citations
4.
Richman, Susan D., Michael Braun, Julian Adlard, et al.. (2006). Prognostic value of thymidylate synthase (TS) expression on failure-free survival of fluorouracil-treated metastatic colorectal cancer patients. Journal of Clinical Oncology. 24(18_suppl). 10011–10011. 5 indexed citations
5.
Turner, Faye, Gillian Smith, D. Timothy Bishop, et al.. (2005). No evidence that polymorphisms in CYP2C8, CYP2C9, UGT1A6, PPARδ and PPARγ act as modifiers of the protective effect of regular NSAID use on the risk of colorectal carcinoma. Pharmacogenetics and Genomics. 15(10). 713–721. 43 indexed citations
6.
Zauber, N. Peter, Marlene Sabbath‐Solitare, Stephen Marotta, et al.. (2005). Clinical and genetic findings in an Ashkenazi Jewish population with colorectal neoplasms. Cancer. 104(4). 719–729. 21 indexed citations
7.
Forrest, Matthew S., S M Edwards, Richard S. Houlston, et al.. (2005). Association between hormonal genetic polymorphisms and early-onset prostate cancer. Prostate Cancer and Prostatic Diseases. 8(1). 95–102. 46 indexed citations
8.
Wachsmuth, Rachel, Faye Turner, Jennifer H. Barrett, et al.. (2005). The Effect of Sun Exposure in Determining Nevus Density in UK Adolescent Twins. Journal of Investigative Dermatology. 124(1). 56–62. 51 indexed citations
9.
Jackson, Sharon, Mark Harland, Faye Turner, et al.. (2005). No Evidence for BRAF as a Melanoma/Nevus Susceptibility Gene. Cancer Epidemiology Biomarkers & Prevention. 14(4). 913–918. 21 indexed citations
10.
Taylor, Claire, Juliette A. Randerson‐Moor, Mark Harland, et al.. (2005). Prevalence of 9p21 deletions in UK melanoma families. Genes Chromosomes and Cancer. 44(3). 292–300. 29 indexed citations
11.
Bertram, Chandra, Jennifer H. Barrett, Juliette A. Randerson‐Moor, et al.. (2004). An Assessment of a Variant of the DNA Repair Gene XRCC3 as a Possible Nevus or Melanoma Susceptibility Genotype. Journal of Investigative Dermatology. 122(2). 429–432. 20 indexed citations
12.
Newton‐Bishop, Julia, Faye Turner, Margaret McCabe, et al.. (2004). A Quality-of-Life Study in High-Risk (Thickness≥2 mm) Cutaneous Melanoma Patients in a Randomized Trial of 1-cm versus 3-cm Surgical Excision Margins. Journal of Investigative Dermatology Symposium Proceedings. 9(2). 152–159. 35 indexed citations
13.
Turner, Faye, Gillian Smith, Christoph Sachse, et al.. (2004). Vegetable, fruit and meat consumption and potential risk modifying genes in relation to colorectal cancer. International Journal of Cancer. 112(2). 259–264. 57 indexed citations
14.
Randerson‐Moor, Juliette A., Faye Turner, Linda Whitaker, et al.. (2004). The Relationship Between the Epidermal Growth Factor (EGF) 5′UTR Variant A61G and Melanoma/Nevus Susceptibility. Journal of Investigative Dermatology. 123(4). 755–759. 37 indexed citations
15.
Bertram, Chandra, Jennifer H. Barrett, Linda Whitaker, et al.. (2002). An Assessment of the CDKN2A Variant Ala148Thr as a Nevus/Melanoma Susceptibility Allele. Journal of Investigative Dermatology. 119(4). 961–965. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026